You missed the point - you are correct statins are the mainstay of treatment and you cannot deny people that treatment .... but ...I have numerous patients that are statin intolerant .... you use that group as a means of leveraging in on the statin market. Likelihood of success in statin naive people should be much higher
News 
Market Data 
Discover 
